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In the mouse mammary tumor virus promoter, a tandem of octamer motifs, recognized by ubiquitous and
tissue-restricted Oct transcription factors, is located upstream of the TATA box and next to a binding site for
the transcription factor nuclear factor I (NF-I). Their function was investigated with mutant long terminal
repeats under different transfection conditions in mouse Ltk- cells and quantitative Si nuclease mapping of the
transcripts. In stable transfectants, which are most representative of the state of proviral DNA with respect to
both number of integrated DNA templates and chromatin organization, a long terminal repeat mutant of both
octamer sites showed an average 50-fold reduction of the basal transcription level, while the dexamethasone-
stimulated level was unaffected. DNase I in vitro footprinting assays with L-cell nuclear protein extracts showed
that the mutant DNA was unable to bind octamer factors but had a normal footprint in the NF-I site. I conclude
that mouse mammary tumor virus employs the tandem octamer motifs of the viral promoter, recognized by the
ubiquitous transcription factor Oct-i, for its basal transcriptional activity and the NF-I binding site, as
previously shown, for glucocorticoid-stimulated transcription. A deletion mutant with only one octamer site
showed a marked base-level reduction at high copy number but little reduction at low copies of integrated
plasmids. The observed transcription levels may depend both on the relative ratio of transcription factors to
DNA templates and on the relative affinity of binding sites, as determined by oligonucleotide competition
footprinting.
Transcriptional control of mouse mammary tumor virus
(MMTV) involves protein factors recognizing and binding to
specific DNA sequences in the proviral long terminal repeat
(LTR). DNA elements mediating positive (40, 57, 69, 70,
110) or negative (40, 45, 57, 70, 73) regulation have been
identified by functional assays in tissue culture cells, and
elements involved in tissue-specific expression have been
defined by analyses of naturally occurring variant LTRs in
pathologic situations (5, 29, 47, 56, 66, 67, 105) or by the
generation of transgenic mice (72, 90; reviewed in reference
44). An important class of positively acting factors com-
prises several types of steroid hormone-receptor complexes:
glucocorticoids (13), progestins (18), and androgens (28).
The hormone responsive element extends to approximately
200 bp upstream of the transcription start site and has been
extensively characterized with respect to the regulation by
glucocorticoids (14, 15, 21, 48, 52, 61, 82) and progestins (17,
20, 41). Analysis by linker-scanning (LS) mutagenesis has
defined multiple, distinct sequence elements acting cooper-
atively to achieve maximal glucocorticoid stimulation of the
MMTV promoter (15, 16, 52). Two of them are located in
DNA segments shown to bind in vitro the purified glucocor-
ticoid receptor: the strongest, distal element (around posi-
tion - 175) cooperates with a weaker proximal one, which in
turn requires a nuclear factor I (NF-I) binding site centered
around position -70 (2, 12, 15, 16, 19, 68, 106). In vivo, NF-I
binding was observed in conjunction with alterations of the
chromatin structure brought about by hormone treatment (3,
27, 81).
In vitro footprinting studies with nuclear protein extracts
of mouse tissues showed a protection against DNase I
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digestion of further sequences (-62 to -37) next to the NF-I
binding site that are related to the octamer/NF-III recogni-
tion motifs and present as a 10-bp direct repeat (65). A
similar configuration of adjacent NF-I and NF-III sites is
found in the DNA of adenovirus type 2, in which both sites
are required for viral DNA replication (84-86). Octamer-
related sequences occur in transcriptional regulatory ele-
ments of several genes, including the promoters of histone
H2B (100) and of immunoglobulin light- and heavy-chain
genes (30, 79) and the enhancers of immunoglobulin heavy
chain (6, 37), Ul and U2 small nuclear RNAs (25, 51, 63),
and simian virus 40 (SV40) (74, 109).
Octamer sequences are recognized by a family of tran-
scription factors that can be either ubiquitous or specific for
certain cell types (reviewed in references 50 and 91). The
factor called Oct-1 (or OTF-1, NF-A1, OBP100, or NE-III)
has been found in every cell type analyzed so far (9, 33, 88,
99, 104), whereas Oct-2 (or OTF-2 or NF-A2) is present
preferentially in B lymphocytes, in which it is involved in the
control of immunoglobulin gene transcription (35, 54, 96,
102). Other members of the octamer family of transcription
factors were found in selected cell types of mouse embryonal
origin (78, 97) or in rat brain tissue (46).
A functional role for the octamer-related sequences in the
MMTV promoter was first defined by Toohey et al. (106) by
using transient-transfection assays in mouse Ltk- cells, in
which mutation of the sequences between -59 and -38 led
to a decrease in transcriptional activity of 10-fold or more
compared with that in the wild type, both in the presence and
in the absence of glucocorticoids. However, another muta-
tional analysis showed a fourfold reduction in hormone-
stimulated activity in HeLa cells transiently cotransfected
with plasmids expressing the glucocorticoid receptor and no
effect on basal transcription determined in a cell-free assay
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(11). Purified Oct-i factor from HeLa cells was shown to
bind to the octamer sequences of the MMTV promoter in
DNase I footprinting experiments (11).
In this study, I investigated the role of the MMTV octamer
motifs by using mutated LTRs under different transfection
conditions, in particular stable transfection, which is more
representative of the state of proviral DNA in virus-infected
cells. In parallel, in vitro footprinting experiments were per-
formed to analyze the interactions of the wild-type and mutated
MMTV promoter region with nuclear protein extracts con-
taining the endogenous factors. The results show that the
main function of the octamer sequence was to control the
basal promoter activity, whereas it only marginally affected
glucocorticoid-induced levels. Relative amounts of template
and factors also played an important role in determining the
final transcription level. This notion was corroborated by the
footprinting results which suggested cooperation of factors
bound to the NF-I and octamer sites in a manner that was
also dependent on the relative factor concentrations and the
nature of the sequences in the recognition sites.
MATERUILS AND METHODS
Plasmid construction. Construction of the LS wild type
and mutants has been described previously (52). LS -66/
-45 was newly constructed and was further used for the
generation of the oct mutant altered in both octamer sites.
For this, the preliminary elimination of an unexpected
BstEII site in the pBR 322 portion (near the PvuII site) was
carried out as follows. LS -66/-45 was digested to comple-
tion with PvuII and partially with BstEII; nearly full-length
linear molecules were isolated by agarose gel electrophore-
sis, made flush with Klenow DNA polymerase and deoxy-
nucleotides, self-ligated, digested with PvuII, and used for
transformation of competent Escherichia coli DH5 bacteria.
A plasmid with only the BstEII site in the MMTV LTR
(positions +105 to +111) was isolated and amplified. The
mutation of both octamer sites was first introduced in a DNA
fragment by PCR with 0.1 pmol of template LS -66/-45 and
20 pmol each of the following deoxyoligonucleotide primers:
a 48-mer with the coding-strand sequence of the oct mutant
(Fig. 1B) between -65 and -18, and a 21-mer with the
non-coding-strand sequence between +130 and +110. The
reaction mixture (0.1 ml) was 20 mM Tris - HCI (pH 8.5), 1.5
mM MgCl2, 25 mM KCI, 0.1 mg of gelatin per ml, and 0.05
mM (each) dATP, dGTP, dTTP, and dCTP. The PCR was
carried out with 1 U of Amplitaq (Perkin-Elmer Cetus) for 20
cycles at an annealing temperature of 55°C, and the product
was purified by extraction with phenol-chloroform and eth-
anol precipitation and then digested with HindIII and
BstEII. The resulting fragment of approximately 175 bp was
purified by agarose gel electrophoresis and ligated to the
gel-purified, 5-kb HindIII-BstEII fragment of the LS -66/
-45 plasmid. After transformation of E. coli DH5 bacteria,
colonies were screened for the presence of plasmids contain-
ing the XhoI site that replaced the distal octamer site (Fig.
1B). Large-scale preparations of plasmids, propagated in E.
coli DH5, were purified by the polyethylene glycol precipi-
tation method (92), and their concentrations were verified by
ethidium bromide staining of agarose gels. The promoter
regions of both mutants were sequenced by the chain termi-
nation method (93) on supercoiled templates (22). All restric-
tion and modification enzymes were used by following the
recommendations of the supplier (Boehringer Mannheim).
Standard molecular biology techniques were applied accord-
ing to established protocols (92).
DNase I footprinting. Nuclear extracts were prepared from
Ltk- cells (treated for 15 h with 10-7M dexamethasone) by
following the method of Shapiro et al. (98) until the precip-
itation with ammonium sulfate. The following inhibitors
were added immediately before use: aprotinin (1%), phenyl-
methylsulfonyl fluoride (0.5 mM to the hypotonic and su-
crose restore buffers and 0.1 mM to the resuspension buffer),
benzamidine (2.5 mM), and NaF (5 mM). The resuspension,
dialysis, and determination of protein concentration by
optical density were performed by the method of Gorski et
al. (39). A total of 40 petri dishes (15-cm diameter; approx-
imately 109 cells) yielded 10 mg of nuclear proteins. Ex-
tracts, at a final concentration of about 5 mg/ml, were stored
in small aliquots in liquid nitrogen. DNase I footprinting
assays were performed by following modifications (58, 65) of
the original method (34), essentially as previously described
(65). Asymmetrically radiolabeled DNA probes were pre-
pared by incubation of plasmids with BamHI (Fig. 1A), calf
intestinal phosphatase, and then [(y-32P]ATP and polynucle-
otide kinase and subsequent digestion with StyI. The 0.45-kb
fragment from the StyI (-303) to the BamHI (+142) sites
was isolated by electrophoresis on a nondenaturing 5%
polyacrylamide gel and electrophoretically eluted (Biotrap;
Schleicher and Schuell). An aliquot was used for the purine
sequencing reaction by the method of Maxam and Gilbert
(64). Labeled fragments (10 fmol) plus 1 Rg of double-
stranded poly(dI-dC) competitor DNA were incubated with
50 to 60 ,ug of nuclear protein extract in 20-,ul binding
reaction mixtures for 30 min at 0°C in a buffer (65) supple-
mented with 5 mM NaF and digested (65) with DNase I
(Worthington) for 5 min at 0°C. Samples without nuclear
extract received a 20-fold dilution of DNase for 2 or 5 min. In
competition experiments, the indicated amount of double-
stranded oligonucleotides in 1 ,ul was added to the binding
reaction mixture 10 min prior to the addition of the labeled
DNA. The competitor oligonucleotides (65) have the follow-
ing sequences: MMTV LTR wild type, from -84 to -58 for
NF-I, and from -62 to -39 for oct; adenovirus type 2 major
late promoter, from -41 to -2 for the unspecific (U)
competitor (Fig. 1C). The reactions were stopped with a
buffer containing sodium dodecyl sulfate and proteinase K
and incubated at 40°C for 1 h, and nucleic acids were
extracted and precipitated in the presence of carrier tRNA
(65). Samples were separated by electrophoresis on 5%
denaturing polyacrylamide gels (64) that were fixed and dried
prior to autoradiography at -70°C with Dupont-Cronex
intensifying screens.
Cell culture and transfection. Mouse Ltk- cells were
cultured in Dulbecco's modified Eagle's medium with 10%
fetal calf serum and antibiotics. Transient transfections were
carried out by the DEAE-dextran method (60) with 5 pLg of
MMTV plasmid and 1 ,g of plasmid H514, containing the
rabbit ,B-globin gene and SV40 enhancer sequences (7). The
cultures, in 10-cm petri dishes, were incubated with DNA for
8 h, subjected to a 10% dimethyl sulfoxide shock (60) for 2
min at room temperature, washed, and incubated with
complete medium for a further 65 h. Dexamethasone (Sigma)
was added to a final concentration of S x 10-7 M 17 h before
RNA extraction. Stable transfections were performed by the
calcium phosphate method (42) with 5 ,ug of the MMTV
plasmids per 6-cm dish as previously described (52). Thymi-
dine kinase (TK)-positive clones were selected with hypo-
xanthine-aminopterin-thymidine (HAT) medium (59). For
hygromycin B selection, 1.5 ,g of a plasmid containing the
hygromycin B resistance gene (8) under the control of the
SV40 promoter was coprecipitated onto the cells. These
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were split 1:3 after 24 h, and selection was started 1 day later
with medium containing 200,ug of hygromycin B per ml. In
both selections, pools of resistant clones from each indepen-
dent transfection were expanded for RNA and DNA analy-
SiS.
Nucleic acid isolation and Si mapping. DNA and cytoplas-
mic RNA were extracted from stably transfected cells as
previously described (14). DNA blot analysis was performed
by the method of Southern (92, 101) with an LTR probe
labeled with 32P by using random oligonucleotide primers
(32). Total cellular RNA was extracted from transiently
transfected cells by the guanidinium thiocyanate method
(24), digested with RNase-free DNase I, extracted with
phenol-chloroform, and reprecipitated with ethanol. For the
S1 nuclease mapping experiments (31), the following 5 -32p-
labeled DNA fragments were prepared for the analysis of
MMTV transcripts, the EcoRI-BamHI fragment of the plas-
mid pA47B (52) extending from -204 to +142; for the
,B-globin internal standard, the 2.5-kb BamHI fragment of
pH514 (52); for the P-actin control, a 425-bp BglII-PvuII
fragment from a SP64 plasmid with the coding portion of the
mouse ,B-actin gene (71) inserted as a PstI fragment. To
obtain a signal of comparable intensity, the specific activity
of the P-actin probe was reduced by adding a 50-fold molar
excess of an unlabeled, linearized plasmid. RNA (25 or 50
,ug) was hybridized to S or 10 fmol of 5'-end-labeled MMTV
or 0-globin probe and 200 fmol of 1-actin probe in 20 [LI at
52°C for 5 to 16 h and digested with 1,300 U of S1 nuclease
(Sigma) per ml for 30 min at 32°C. The protected fragments
were separated on denaturing 6% polyacrylamide gels (64)
and subjected to autoradiography with intensifying screens.
The intensity of the bands was measured by densitometric
scanning of films after various exposure times.
RESULTS
Construction of MMTV LTRs mutated in the promoter
region. For the functional analysis of the MMTV promoter,
mutations were introduced in an almost complete MMTV
LTR (from the PstI site 8 bp into the LTR sequence to the
PvuII site at its 3' end) linked to the coding region of the TK
gene of herpes simplex virus (Fig. 1A). The wild-type
plasmid (pLSwt) and the generation of LS mutants, by
ligation of a 3'-deleted and a 5'-deleted moiety via a syn-
thetic linker containing a HindIII restriction site, have been
described (52). For the present study, the target sequence for
mutagenesis was a 10-bp direct repeat located immediately
upstream of the TATA box (Fig. 1B) that contains consensus
octamer motifs able to bind in vitro the ubiquitous transcrip-
tion factor Oct-1 (11). To rigorously test the role of the
octamer sites, they were both mutated without altering
relative distances in the DNA. The oct mutant (Fig. 1B) was
produced by PCR with an oligonucleotide carrying a HindlIl
site (for ligation into pLS -66/-45) and a XhoI site (for
selection) replacing the distal octamer site, the proximal site
being mutated by transversions. The sequence alterations
involve the positions -61 to -39 from the transcription start
site and were verified by sequencing. The construct is
otherwise identical to pLSwt, with a minor sequence differ-
ence in the plasmid portion of both mutants due to the
suppression of an unexpected BstEII site. Another mutant,
LS -66/-45, has a 12-bp deletion, including the distal
octamer motif, whereas the adjacent palindromic recognition
sequence for NF-I is reconstituted by the HindIII linker.
Therefore, it contains only one copy of the octamer motif,
with unchanged distances to the NF-I site and the TATA
box, and is shorter by approximately one turn of the DNA
helix (Fig. 1B).
Binding of nuclear proteins to wild-type and mutant pro-
moters. As a preliminary test, we investigated the ability of
the mutants, in comparison to wild-type LTR, to bind
nuclear proteins from mouse Ltk- cells. These are the cells
chosen for functional assays, as they are permissive for the
function of the MMTV promoter and for a strong transcrip-
tional stimulation by glucocorticoid hormones (13-15, 106).
End-labeled DNA fragments spanning the promoter region
were incubated with nuclear extracts of dexamethasone-
treated Ltk- cells and subjected to mild digestion with
DNase I in a footprinting experiment (Fig. 2). The pattern of
protection of wild-type DNA in the basal promoter region
shows a continuous footprint from -82 to -24 that includes
the recognition sequences of NF-I and Oct-1/NF-III, plus
the TATA box. A second footprint extending from -8 to
+20 includes the RNA start site. Finally, at least two distinct
protected areas are visible in the distal region upstream of
-170, one of them containing the glucocorticoid receptor
binding site. Although on the opposite DNA strand and with
a different resolution, the wild-type pattern follows closely
the one described previously for Ltk- cells (65). In contrast,
DNA mutated in both octamer sites between positions -38
and -62 (Fig. 2, OCT mut) showed, as predicted, a loss of
protection in the octamer region, while maintaining a clear
NF-I footprint next to it. The TATA box area showed an
altered pattern, interrupted by a new hypersensitive site at
-31. No changes were detectable in the footprint spanning
the cap site or in those of the distal region. DNA of the LS
-66/-45 mutant is clearly protected in the NF-I region.
Further downstream, it shows a footprint corresponding to
the single octamer site between -35 and -45 and a weak one
corresponding to the TATA box, without interruptions by
hypersensitive sites. These are present at the outer edges of
the promoter region (at -23 and -85) as in wild-type DNA.
Again, no alterations were observed in the other protected
sites downstream or upstream. These data show that in
vitro, the mutant LTR DNAs have the predicted properties
of binding nuclear factors.
Transcriptional activity of promoters mutated in the oc-
tamer motifs. The functional effect of the octamer mutation
was first tested in transient-expression assays with Ltk-
cells that were treated with 5 x 10-7 M dexamethasone, a
synthetic glucocorticoid, for 17 h before RNA extraction.
The MMTV plasmids were cotransfected with a reference
plasmid containing the rabbit ,B-globin gene under the control
of the SV40 enhancer (7). Correctly initiated, stable mRNAs
were detected in nuclease S1 protection experiments with
5'-end-labeled DNA probes that span the RNA initiation site
for MMTV and the beginning of the second exon for the
globin gene (62). After being annealed with RNA, labeled
fragments of 142 nucleotides (nt) for MMTV and 212 nt for
globin were protected from S1 digestion, and the intensity of
these bands was quantitated by densitometry of the autora-
diographs. Figure 3 shows the results of independent trans-
fection assays with the mutant of both octamer sites and the
wild-type plasmid for comparison. The average of the ratios
of the intensity of the MMTV-specific band to that of the
reference globin band was 2.09 (+0.21) for the wild type and
1.47 (+0.20) for the octamer mutant, which therefore dis-
played an average transcriptional activity of about 70% of
that of the wild type (between 55 and 89%, considering the
extremes of the standard deviation). This result shows that
in transient assays, the mutation in the octamer sites did not
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A
LTR
B
WT
-90
B
-70
TK
-50
P
-30
TTCCTATGTTCTTTTGGAATCTATCCAAGTCTTATGTAAATGCTTATGTAAACCATAATATAAAAGAGTGC
NF-I OCT OCT TATA BOX
OCT MUT. TTCCTATGTTCTTTTGGAATCTATCCAAGCtTgCTCgAgCTGCTgCgtgCCCCCATAATATAAAAGAGTGC
LS,12 66/45 TTCCTATGTTCTTTTGGAATCTATCCAAG-CTT--G---------ATGTAAACCATAATATAAAAGAGTGC
LS.11 90/70 T--CaA-G--CTT--G----CTATCCAAGTCTTATGTAAATGCTTATGTAAACCATAATATAAAAGAGTGC
C
5'GTTCTTTTGGAATCTATCCAAGTCTT 3'
3'CAAGAAAACCTTAGATAGGTTCAGAA 5'
5'GTCTTATGTAAATGCTTATGTAAA 3'
3'CAGAATACATTTACGAATACATTT 5'
NF-I
OCT
5'GAAGGGGGGCTATAAAAGGGGGTGGGGGCGCGTTCGTCC
3'CTTCCCCCCGATATTTTCCCCCACCCCCGCGCAAGCAGG 5' UNSPEC.
FIG. 1. (A) Wild-type plasmid (52). The LTR of MMTV (GR strain) from the PstI to the PvuII sites is linked via a BamHI linker to the
herpes simplex virus TK coding region (BglII-PvuII fragment). The hormone regulatory element (shaded area) extends to about 200 bp
upstream of the transcription start site (14). The arrow denotes the RNA, and the line below it denotes the protected 142-nt fragment in Si
mapping experiments. Restriction enzyme sites are as follows: B, BamHI; Ps, PstI; and P, PvuII. (B) Sequences of wild-type and mutated
promoters. For the NF-I site, the arms of the palindrome and the center at -70 are underlined. The octamer-related motifs are doubly
underlined; seven of eight bases are repeated and were considered for mutation. Wild-type sequences are in capital letters, and mutated ones
are in lowercase letters; deleted bases are indicated by hyphens, located arbitrarily to maximize the number of matches. Relevant restriction
enzyme sites are in boldface letters: HindIII (AAGCIT) of LS mutants and XhoI (CTCGAG) for selection of the PCR-generated oct mutant.
(C) Sequence of the double-stranded oligonucleotides used in competition footprinting experiments.
produce a major effect on the level of glucocorticoid-stimu-
lated RNA.
The position of the octamer sequences in front of the
TATA box may suggest that they play a role in the basal
activity of the MMTV promoter. In view of apparently
conflicting data in recent reports (11, 106), I decided to
examine this possibility with the mutants. As the sensitivity
of transient-transfection assays does not allow the detection
of unstimulated levels of RNA, I carried out stable transfec-
tion experiments with Ltk- cells with the octamer mutant,
the single-site deletion mutant LS -66/-45, or the wild-type
plasmid. Stable transfection has the advantage of reflecting
more closely the situation of proviral DNA in infected cells.
Two selection procedures were applied for the isolation of
transfectants: cotransfection with a plasmid conferring resis-
tance to the antibiotic hygromycin B (8) or selection for
TK+ cells in HAT medium (59). Independent pools of
transfected cells were expanded in selective medium, and
parallel cultures were grown in the presence or absence of
dexamethasone for 17 h prior to RNA extraction. Si nucle-
ase protection assays were performed, and dilutions of the
dexamethasone-stimulated samples were loaded on a se-
quencing gel next to the undiluted corresponding control
samples.
From the autoradiographs shown in Fig. 4, two points are
immediately obvious: (i) there is no major difference be-
tween signals due to dexamethasone-stimulated RNA in
mutants and the wild type (Fig. 4A, lanes a and b, and Fig.
4B, lanes a, b, and c), and (ii) a strong reduction of the
unstimulated RNA levels is apparent in the oct mutant
transfectants, particularly in the hygromycin B-selected
ones (Fig. 4A, lanes c of pools 5 to 8). Densitometry of the
autoradiographs and standardization according to the con-
trols (see legend to Fig. 4) yielded the data in Fig. 5.
Histograms represent absolute values in arbitrary units that
allow a direct comparison between mutants and the wild
type within each panel. Induction factors cannot be derived
directly; for the wild type, they were in the range of 60 to 160
in hygromycin-selected transfectants and 10 to 50 in TK+
ones. The quantitative data confirmed that the effect of the
double octamer mutation was on the basal level of transcrip-
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FIG. 3. Transient-expression assays of wild-type and octamer-
mutated DNA analyzed by S1 nuclease protection experiments.
Each lane contains the reaction product of an independent cotrans-
fection of an MMTV plasmid with the rabbit 3-globin internal
standard plasmid pH514. The cultures were treated with dexameth-
asone for 17 h before RNA extraction. The autoradiograph of the
denaturing gel displays the 5'-end-labeled protected fragments cor-
responding to the MMTV LTR probe (MTV, 142 nt) and the globin
probe (GI., 212 nt).
basal levels: as the wild type in hygromycin-selected trans-
-__ fectants (Fig. 5A) and as an octamer mutant in TK+ trans-
20-- fectants (Fig. 5C). For the interpretation of the results, it was
important to know the number of templates present in the
different transfectants. Therefore, in Fig. 5, the approximate
copy numbers of integrated plasmids, as determined by
Southern transfer analysis of the DNA of each transfected
-1-- pool, are indicated. Not unexpectedly, on the basis of the
4WAO experimental setup, this control underlined a major differ-
ence between the two types of transfectants: those obtained
- via independent selection for antibiotic resistance contained
_10- grossly comparable numbers (4 to 20) of plasmids. When
calculated per template unit compared with the wild type,
the average basal RNA levels were reduced about 50-fold in
-
- the octamer mutant transfectants and about 2-fold in the
single-octamer site LS -66/-45 transfectants. On the con-
_83 ~3 trary, those obtained through TK selection had copy num-
_ft bers that were low for the wild-type plasmid and 10- to
--- 100-fold higher for both mutants. In this situation, the
F NE selective pressure was exerted on the TK gene product
ith L-cell nuclear ex- under the control of the (nonstimulated) MMTV promoter
tated in both octamer itself, and a minimal level of TK protein was required for cell
-tamer site (LS 66/45). survival in HAT medium. Because the unstimulated MMTV
-142 and extending to promoter is relatively weak, this experimental setup was
, free DNA) or in the used previously to select for multiple-copy transfectants
purine sequence of the with a detectable basal level of RNA (13, 15). The finding of
nposite footprint in the elevated mutant plasmid levels in the transfectants suggests
in the mutated DNAs. that a selection for fortuitously high-copy-number clonesmndIII linker is marked had occurred or that the transfected DNA had undergone an
mutated sequence (in)
amplification to compensate for the lower transcriptional
efficiency of the mutated promoters. Yet the cumulative
basal RNA levels remained about 10-fold lower in the
mutants than in the wild type, resulting in a total reduction
xamethasone-stimu- factor per DNA copy in the order of 100-fold. In summary,
the results show that dexamethasone-induced RNA levels
as observed for the were not reduced to a large extent by either octamer
with respect to the mutation, whereas the basal level was severely lowered by
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FIG. 4. Si mapping analysis of RNA from independent pools of stably transfected cells (indicated by numbers). (A) Hygromycin
B-selected transfectants. RNA from dexamethasone-treated cultures was analyzed in lanes a and b, and that from parallel untreated cultures
was analyzed in lanes c. M, 142-nt protected fragment of the MMTV LTR probe; Ac, mouse ,-actin-protected fragment as an internal control
(this probe was missing in lanes 4a and 4b). A total of 5 ,ug of dexamethasone-treated RNA plus 20 ig of yeast RNA was annealed to
5'-end-labeled probes for MMTV (10 fmol) and P-actin (200 fmol; 50-fold-lower specific activity). After S1 digestion, dilutions of the samples
corresponding to 0.75 ,ug (lanes a) and 3 jig (lanes b) of RNA were loaded on the gel. For the analysis of non-dexamethasone-treated RNA,
two annealing reaction mixtures with (i) 50 Ag of RNA and 10 fmol of MMTV probe and (ii) 5 p.g of RNA plus 20 p.g of yeast RNA and 200
fmol of P-actin probe were mixed for the S1 digestion and subsequent handling, and the whole sample was loaded on the gel (lanes c). (B)
HAT-selected, Ltk+ transfectants. RNA from dexamethasone-treated cultures was hybridized with the 5'-end-labeled MMTV LTR probe,
and dilutions of the final samples equivalent to 3 pLg (lanes a), 1.5 pLg (lanes b), or 0.75 ,ug (lanes c) of RNA were loaded on the gel. Lanes
d, products of reactions with 50 ,ug of RNA from parallel untreated cultures. The autoradiographs show the 142-nt MMTV-specific band.
the complete octamer mutation both at high and at moderate
copy numbers. The deletion mutant of only one octamer site
showed an intermediate result, in that the base level was
reduced only at high copy numbers (the state of the inte-
grated DNA templates may play a role in this particular case
[see Discussion]).
In vitro interactions of promoter-bound nuclear proteins.
Purified NF-I, Oct-1/NF-III, and glucocorticoid or progest-
erone receptor have been shown to bind individually to their
cognate sites on the MMTV DNA in the promoter/upstream
region (11, 12, 20, 76, 95). When present together, purified
Oct-1 and glucocorticoid or progesterone receptor displayed
synergistic binding to their respective sites (11). However,
this type of study does not take into consideration the
relative abundance of factors in the nucleus and their affin-
ities for DNA in the presence of the other nuclear proteins.
When crude nuclear extracts were used in footprinting
experiments, the binding pattern reflected more accurately
the relative functional strength of glucocorticoid regulatory
elements (65). Because of the proximity of the recognition
sequences for Oct-1 and NF-I in the MMTV DNA, and in
view of previous results implicating the NF-I site in the basal
level of MMTV RNA synthesis (16), we analyzed the spec-
ificity of the protein-DNA interactions in competition assays
with double-stranded oligonucleotides and the wild-type or
the mutant labeled probes incubated with Ltk- nuclear
extracts (Fig. 6). As a control, a high molar excess of an
unspecific competitor with the sequence of the promoter
region of adenovirus type 2 (94) did not alter the DNase I
protection patterns (Fig. 6, lane 8) compared with that in the
absence of any competitor (Fig. 6, lane 4). In contrast,
preincubation with increasing amounts of an oligonucleotide
containing the NF-I recognition sequence (Fig. 6, lanes 5 to
7, bp -83 to -58) inhibited the footprint in the homologous
DNA segment of all three probes but also gave a partial
competition in the octamer region when binding sites were
present (in wild-type and LS -66/-45 DNAs). In these same
probes, however, displacement of proteins bound to the
octamer sites by an oligonucleotide with the homologous
sequence (Fig. 6, lanes 9 to 11, bp -62 to -37) did not alter
binding to the adjacent NF-I site. Addition of the octamer
oligonucleotide also displaced proteins bound to the tran-
scription initiation area (+1 to +5). As this effect was also
observed in the octamer-mutated DNA and was therefore
not dependent on the presence of octamer-bound factors in
their cognate sites, it could not be due to interaction of
DNA-bound proteins in the octamer and cap sites. Compe-
tition was also seen in the distal region, affecting a footprint
between approximately -175 and -185 and another one
around -215 to -220. While the latter is still uncharacter-
ized, the one at -175 to -185 is likely to be due to the
endogenous glucocorticoid receptor, as the nuclear extracts
were prepared from dexamethasone-treated Ltk- cells. The
identity of a similar footprint observed with mouse liver
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FIG. 5. Quantitation of MMTV-specific transcription in stably transfected cells. The S1 mapping results of the experiments shown in Fig.
4 were analyzed by densitometry of films in the linear range of intensities for the bands of interest. The data were standardized according to
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(a.u.). The values can be compared only within each panel. The approximate number of copies of integrated MMTV plasmids was estimated
from the intensity of transfected LTR bands in Southern hybridization analyses, by using the mouse endogenous MMTV bands as standards.
extracts has been previously established by using competi-
tion with mutated oligonucleotides and with a specific anti-
body (65). A similar cross-competition pattern by the oc-
tamer region oligonucleotide has been described by the same
authors (65).
The competition experiments described above (Fig. 6)
showed that factors did bind to the NF-I recognition se-
quence independently from the occupancy of the adjacent
octamer sites or from the removal of octamer-binding pro-
teins in the extract, whereas the binding of factors to the
octamer sites did require, at least partially, the presence of
NF-I on its site. In a previous study (16) we had analyzed a
mutant of the NF-I site, LS -90/-70, that retains only the
proximal half of the palindrome and is shorter by one helix
turn (Fig. 1B). Its phenotype was a reduced ability to
cooperate with the proximal glucocorticoid-responsive ele-
ment in the hormonal induction and also a reduction in the
basal, unstimulated RNA level by a factor of 3 to 5.
Competition DNase I footprinting with the NF-I, octamer,
or unspecific oligonucleotides was performed on this mu-
tated DNA probe. Figure 7 shows that, in striking contrast to
the wild-type situation, competition by the octamer se-
quence displaced efficiently the protein bound in the NF-I
half-site. Competition by the NF-I sequence was also more
efficient in displacing octamer-bound factors, as the footprint
disappeared at a lower concentration of competitor (200-fold
molar excess) than with the wild-type probe (500-fold molar
excess). In summary, the data of Fig. 6 and 7 together
suggest a nonreciprocal cooperation of NF-I in the binding of
octamer-type factors on the wild-type MMTV DNA and a
reciprocal stabilization of binding when only half of the NF-I
palindromic recognition sequence is present.
DISCUSSION
In this study, the transcriptional role of octamer factor
binding to a tandem motif present in front of the TATA box
in the MMTV promoter was investigated. The use of stably
transfected cells, containing relatively low levels of inte-
grated plasmids, showed the importance of the copy num-
ber, affecting the ratio of factor to DNA template, for the
functional outcome. Virus-infected cells contain only a few
(1 to 20) integrated proviruses (26, 43), and this situation is
not necessarily comparable with that found in transiently
transfected cells, in which DNA templates are present in
large numbers (thousands per cell). Two mutagenesis studies
of the MMTV octamer sites carried out with transient-
expression assays in L cells (106) or HeLa cells (11) had
shown an effect of octamer site mutations on the glucocor-
ticoid response, to various extents; one study also showed
an effect on base-level transcription (106). While the DNA
sequences that replace the octamer sites differ and may
influence the results, we also found a relatively small reduc-
tion of dexamethasone-stimulated RNA levels in transient
assays monitored by quantitative S1 mapping. However, this
was not the case when the mutants were analyzed under
stable transfection conditions that allowed a separation of
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corresponding to the NF-I (-83 to -58) or octamer (-62 to -39) binding sites of MMTV DNA. DNA fragments 5' end labeled at position
+142 and extending to -303 were incubated with L-cell nuclear extract (lanes 4 to 11) or in its absence (lanes 2 and 3, free DNA [F]) and
subjected to DNase I digestion. In competition experiments (lanes 5 to 11), double-stranded oligonucleotides were preincubated with the
extracts in molar excesses of 50-, 150-, and 450-fold, respectively, in lanes a (lanes 5 and 9), b (lanes 6 and 10), and c (lanes 7 and 11). The
unspecific competitor (U, lane 8) from the adenovirus promoter was added at a 500-fold molar excess. No competitor was added in lane 4.
Lanes marked GA contain the purine sequencing reactions of the probes. Continuous vertical lines mark the positions of the relevant
footprints, and a broken line marks that of the mutated sequences in the octamer mutant.
the effect on basal promoter activity from that on hormonally
stimulated transcription.
Another important parameter for the interpretation of the
functional studies is the relative affinity of DNA sites for
transcription factors that was evaluated in the original se-
quence context by competition footprinting with nuclear
protein extracts and wild-type or mutant DNA probes. I
found that the binding affinity, together with the relative
concentration of factors, may explain the transcriptional
behavior of the MMTV promoter mutants, in a manner that
is reminiscent of the regulation of immunoglobulin gene
promoters by octamer factors (49). In MMTV, a further level
of complexity is given by the peculiar arrangement of
octamer and NF-I binding sites, similar to that observed for
adenovirus type 2, in which both are needed for initiation of
DNA replication (75, 84, 89) through simultaneous binding of
NF-I and Oct-1 (84). The distance between the center of the
NF-I palindrome and the firstA of the octamer motif is 10 bp
in adenovirus type 2 and 14 bp in MMTV DNA.
The octamer sites are mainly involved in basal-level MMTIV
transcription. The data on stably transfected cells with the
complete octamer site mutant showed that the mutation
MOL. CELL. BIOL.
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Earlier studies have shown that the bas
scription from the MMTV promoter is als
30 70 fected by mutations in the NF-I binding site both in transient
assays (106) and in Ltk+ stable transfectants (16, 52). The
latter ones, produced in this laboratory in a way analogous to
that of the present study, showed no increase in the number
of integrated plasmids compared with wild-type transfec-
tants. In one instance, in which an independent selection
with hygromycin B was also used, this did not alter the
relative differences in MMTV RNA levels between stimu-
lated and unstimulated cultures or between mutants contain-
ing a complete or a half-NF-I binding site (52). These
observations are consistent with the quantitative differences
in the basal-level reductions, which were 50- to 100-fold in
NF octamer site mutants and only 2- to 5-fold in NF-I mutants
OCT (in which the residual levels of TK mRNA were apparently
sufficient to allow the survival of transfectants without a
need for a higher number of templates). A tentative expla-
nation for the effect of NF-I site mutations on the basal level
may be found in the stabilizing function exerted by the
occupied NF-I sequence on the binding of octamer factors to
their site, which was observed with oligonucleotide compe-
titions in footprinting experiments with nuclear extracts
(Fig. 6 and 7). It is conceivable that a mutation of the NF-I
site that reduces (Fig. 7) or abolishes NF-I binding would
destabilize the interaction of Oct-1 with its sites, leading to a
lowered base level of transcription. Mutual stabilization of
_ DNA binding between Oct-1 and another protein (OAP40)
recognizing a site 5' to an octamer motif has been described
NFa Oc for the antigen-inducible interleukin-2 enhancer (108).
ild-type DNA (WT) The NF-I binding site is mainly involved in glucocorticoid-
F-I site (LS 90/70) stimulated MMTV transcription. The data from stably trans-
ner site oligonucle- fected cells also show that neither octamer mutant affected
e described in the the hormone-induced levels (Fig. 4 and SB and D). In the
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a 300-fold excess. DNA copies. In the DNase I footprints with nuclear ex-
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strong even in the octamer mutant DNA and was not
t the dexametha- affected by competition with octamer oligonucleotides (Fig.
dichotomy of the 6). This independence of NF-I binding seems to correlate
vel transcription with the unaltered dexamethasone response in L cells con-
nbined effects of taining stably integrated octamer site mutant plasmids. Only
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(Fig. 6) showed tion (about 30%) of dexamethasone-induced levels for the
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;o the single-site indirect effect on NF-I binding in the following way. As
tmutant. On the shown by the oligonucleotide competition footprinting data
DNA decreases ofFig. 7, in an unfavorable situation like the reduction of the
he higher-affinity recognition site to the half-palindrome (in LS -90/-70), the
tor is saturating, binding of NF-I was not autonomous as in the wild type but
uence of the oct required the concomitant binding of Oct factor to the neigh-
ient even at the boring sites, possibly to help stabilize the weaker DNA-
iose in wild-type protein interactions. In the conditions of vast template
i mutant with an excess of transiently transfected cells, even the wild-type
tively low copy NF-I site might need the octamer factor bound nearby. Its
ig. SC). It is also absence in oct mutant DNA might therefore destabilize NF-I
ure, the starting binding and indirectly affect the dexamethasone-induced
han in the hygro- level of transcription. The role of NF-I in the glucocorticoid
carrying a large stimulation of MMTV expression has been established in
ough progressive several studies involving transfection of mutant promoters
rent organization into various cell types (11, 15, 16, 19, 41, 68, 106). Moreover,
ties of plasmids, NF-I was shown to act as a hormone-dependent transcrip-
viously observed tion factor when its cDNA was introduced into deficient
cific activity per JEG-3 choriocarcinoma cells, resulting in an increase of
dexamethasone-stimulated RNA but not of the base level
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progestins (19, 41). In cell-free transcription assays supple-
mented with glucocorticoid receptor, the NF-I binding site
of MMTV showed a synergism with the glucocorticoid
response element (2).
The results presented in this study demonstrate that
effects on basal and induced transcription levels can be
functionally separated and suggest a dependence on the
concentration of factors and on the affinity of the corre-
sponding DNA sites. One may predict that the asymmetry in
the affinities of Oct-1 and NF-I for their respective DNA
sequences in the MMTV promoter would be reflected in
asymmetric responses to a lower concentration of one fac-
tor, depending on the cell type. A low amount of Oct-1
would bring about a low basal transcription level without
affecting the maximal hormone inducibility, whereas a low
amount of NF-I would give a reduction, but to a lesser
extent, of both induced and basal levels. A large excess, or
limiting amounts, of both factors would affect, positively or
negatively, the base level more than the induced one.
Therefore, it appears that the basal level of MMTV expres-
sion would be more subject to modulation by the availability
of certain ubiquitous transcription factors, whereas the
hormone-receptor complex would be the major determinant
for a plateau of maximal transcriptional activity. These
predictions can be tested in stable transfections with an
independent selection.
Implications for the chromatin organization of MMTV
DNA. The MMTV promoter was shown to be organized in
nucleosomal structures in bovine papillomavirus-based epi-
somes and in single integrated copies as well (3, 4, 81, 87). A
phased array of nucleosomes is observed when the MMTV
DNA is in a stable configuration within the cells but not
when it is introduced in a transient fashion (4). Fine mapping
has shown that the core of a nucleosome is positioned on the
DNA segment spanning from -221 to -75 that includes both
distal and proximal glucocorticoid response elements and
the NF-I binding site at its 3' edge. Another nucleosome is
positioned on the TATA box and the beginning of the
transcribed region, with its core between -23 and +123,
while the linker between these nucleosomes comprises the
octamer motifs (10). The fundamentally different organiza-
tion of stable versus transient chromatin was also shown by
the observation that NF-I is constitutively present on tran-
sient templates but excluded from stable templates in the
unstimulated state and only detectable upon glucocorticoid
stimulation (4). It is believed that the binding of the hormone
receptor (which can occur in the presence of the nucleosome
core, contrary to NF-I) induces a structural transition of the
chromatin that allows access of NF-I to it (3, 4, 27).
However, this fact could not explain the results of functional
assays. Indeed, transcription from transient templates is also
strongly hormone inducible, indicating that the receptor is
the major determinant of the induction; on the other hand, a
basal level of transcription is also observed with stable
templates (in the absence of NF-I), making questionable its
role in basal promoter function. The present results suggest
such a role for the octamer-binding factor Oct-1. The inabil-
ity to detect Oct-1 by in vivo footprinting assays (10) is likely
due to its weak binding. The in vivo mapping assigned the
octamer sites to the linker region between nucleosomes,
where the presence of histone Hi was demonstrated by
cross-linking and immunoadsorption studies (10). The affin-
ity and concentration dependence of Oct-1 discussed above
may then be exerted in competition with Hi, as described for
other transcription factors (55). A reduction in the amount of
Hi per nucleosome upon dexamethasone activation has
been reported (10) and may reflect a stabilization of an
Oct-1/NF-I complex onto the DNA as a consequence of the
formation of larger arrays with several receptors, leading to
more efficient transcription. An indication of hormone-in-
duced recruitment of a TATA-binding protein on transient
templates has been obtained by in vivo exonuclease III
mapping (4).
Other factors. The results of the footprinting experiments
with L-cell nuclear extracts (Fig. 6 and 7), showing a
competition by the octamer oligonucleotide in the distal
region and at the cap site, are similar to those obtained with
mouse liver extracts (65) and suggest that ubiquitous factors
are involved. As the competition was also found with DNA
mutated in the octamer motifs, it is likely to be due to
titration of factors in solution, directly or via accessory
proteins, and not to the absence of Oct factors in their sites.
The competition in the distal area involves the receptor
binding site, and indeed a recent report showed that the
Oct-1 factor can engage in direct protein-protein interactions
with the glucocorticoid receptor in vitro and produce a
functional interference in transfection assays (53). As for the
pronounced competition in the +2 to +5 area, it may involve
the newly identified factor ISBP (for initiation site binding
protein [80]), but further analyses will be required to clarify
this point. In particular, it remains to be determined by
which mechanism Oct-1 activates the basal MMTV pro-
moter in a receptor-independent manner. This may well
occur through association with cellular transactivating fac-
tors, by analogy with its interaction with the herpes simplex
virus VP16 protein (36, 77, 83, 103). Finally, through the
binding to the B-cell-specific Oct-2 factor, but possibly to the
ubiquitous Oct-1 as well (49), the octamer sites may play a
role in the transcription of MMTV in lymphocytes. These
are among the first cells infected by the virus in mice (107),
and they express a viral LTR-encoded protein with super-
antigen functions, leading to selective elimination of specific
T-cell clones (1, 23, 38).
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